Share this article
Share this article
ResearchAndMarkets.com s offering.
The global cardiac rhythm management devices market size is anticipated to reach USD 29.9 billion by 2028 and is expected to expand at a CAGR of 7.4% from 2021 to 2028.
The market has shown constant growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the CDC, as of September 2020, approximately 655,000 Americans die suffering from heart disease every year.
The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic. Major players in the market, such as Medtronic, Abbott, and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020.
Global Cardiac Rhythm Management Devices Markets, 2016-2020 & 2021-2028 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Global Cardiac Rhythm Management Devices Markets, 2021-2028 - Focus on Pacemaker, Defibrillators, CRT Devices - ResearchAndMarkets.com
April 27, 2021 GMT
DUBLIN (BUSINESS WIRE) Apr 27, 2021
The global cardiac rhythm management devices market size is anticipated to reach USD 29.9 billion by 2028 and is expected to expand at a CAGR of 7.4% from 2021 to 2028.
The market has shown constant growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the CDC, as of September 2020, approximately 655,000 Americans die suffering from heart disease every year.
(0)
SAN FRANCISCO, April 12, 2021 /PRNewswire/ The global sleep apnea devices market size is expected
to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Obesity is a major factor in sleep apnea. The global prevalence of obesity is estimated to reach 18.0% in men and 21.0% in women by 2025. This, in turn, is estimated to drive the market as more than half of the overweight or obese people suffer from Obstructive Sleep Apnea (OSA).
Key suggestions from the report:
Therapeutic devices emerged as the leading type segment in 2020 with a revenue share of 76.9% in the market
Share this article
SAN FRANCISCO, Feb. 11, 2021 /PRNewswire/ The global defibrillator market size is expected
to reach USD 22.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 7.4% from 2021 to 2028. Factors contributing to the growth of this market include supportive legislative reforms, rising incidences of sudden cardiac arrests in the region, presence of integrated technology, and rising awareness for cardiac conditions. Moreover, the COVID 19 pandemic further accentuated the need for defibrillators as many elderly patients suffering from COVID-19, suffered from sudden cardiac arrests, and the device was useful for the resuscitation of such patients.